List view / Grid view

Karolina Heed - Global Solution Manager Endotoxins at bioMérieux

 

article

Expert View: Advancing bacterial endotoxin testing with recombinant Factor C

7 May 2019 | By

Emerging recombinant Factor C (rFC) methods have many advantages to offer pharmaceutical quality control, including improved specificity, robustness, efficiency and alignment with 3R principles. First, global manufacturers have validated rFC and pharmacopoeias worldwide are on the move. Here, Karolina Heed provides an industry and regulatory update.